Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Immucell Corp (ICCC)

Immucell Corp (ICCC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 53,552
  • Shares Outstanding, K 9,046
  • Annual Sales, $ 26,490 K
  • Annual Income, $ -2,160 K
  • EBIT $ 2 M
  • EBITDA $ 5 M
  • 60-Month Beta 0.18
  • Price/Sales 1.97
  • Price/Cash Flow 95.65
  • Price/Book 1.87

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.48 +15.88%
on 12/08/25
7.12 -10.81%
on 12/26/25
+0.71 (+12.59%)
since 12/05/25
3-Month
4.52 +40.49%
on 11/21/25
7.12 -10.81%
on 12/26/25
unch (unch)
since 10/06/25
52-Week
4.28 +48.36%
on 03/13/25
7.60 -16.45%
on 06/20/25
+0.86 (+15.77%)
since 01/06/25

Most Recent Stories

More News
ImmuCell Announces Strategic Focus on First Defense® After Receiving an FDA Incomplete Letter for Re-Tain®

PORTLAND, Maine, Dec. 24, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell”), an animal health company that develops, manufactures and markets products that improve cattle...

ICCC : 6.35 (+4.96%)
ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2025

PORTLAND, Maine, Nov. 13, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets...

ICCC : 6.35 (+4.96%)
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2025

PORTLAND, Maine, Nov. 06, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC)  (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets...

ICCC : 6.35 (+4.96%)
ImmuCell Announces Onboarding of New CEO and Related Management Changes

PORTLAND, Maine, Nov. 04, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets...

ICCC : 6.35 (+4.96%)
ImmuCell Announces Preliminary, Unaudited Sales Results for Q3 of 2025

PORTLAND, Maine, Oct. 07, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets...

ICCC : 6.35 (+4.96%)
ImmuCell Announces Selection of its Next President and CEO

PORTLAND, Maine, Sept. 29, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets...

ICCC : 6.35 (+4.96%)
ImmuCell Swings to Q2 Profit on Strong Sales, Shares Still Slide

Shares of ImmuCell Corporation ICCC have declined 7.4% since the company reported its earnings for the second quarter of 2025. This compares unfavorably with the S&P 500 index, which slipped just 0.8%...

ICCC : 6.35 (+4.96%)
ImmuCell Announces Unaudited Financial Results for the Quarter Ended June 30, 2025

PORTLAND, Maine, Aug. 14, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets...

ICCC : 6.35 (+4.96%)
ImmuCell Announces Bank Debt Refinancing

PORTLAND, Maine, Aug. 12, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets...

ICCC : 6.35 (+4.96%)
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2025

PORTLAND, Maine, Aug. 07, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets...

ICCC : 6.35 (+4.96%)

Business Summary

ImmuCell Corp. is a biotechnology company striving to build shareholder value by commercializing proprietary technologies and helping dairy and beef producers and their veterinarians manage disease and reproduction in their herds. The company is also conducting an open label, efficacy study of DiffGAM,...

See More

Key Turning Points

3rd Resistance Point 6.87
2nd Resistance Point 6.62
1st Resistance Point 6.49
Last Price 6.35
1st Support Level 6.11
2nd Support Level 5.86
3rd Support Level 5.73

See More

52-Week High 7.60
Last Price 6.35
Fibonacci 61.8% 6.33
Fibonacci 50% 5.94
Fibonacci 38.2% 5.55
52-Week Low 4.28

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar